Skip to site navigation Skip to main content Skip to footer content Skip to Site Search page Skip to People Search page

Releases and Announcements

Duane Morris Partner Thomas Kowalski Named as Patent Strategy Attorney of the Year by LMG Life Sciences

September 7, 2023

Duane Morris Partner Thomas Kowalski Named as Patent Strategy Attorney of the Year by LMG Life Sciences

September 7, 2023

Read below

PHILADELPHIA, September 7, 2023Tom Kowalski was recognized as Patent Strategy Attorney of the Year at the LMG Life Sciences Awards dinner in New York. The 11th annual awards ceremony highlighted the best in regulatory, corporate, intellectual property and litigation legal practices following a thorough survey of life sciences sector practitioners and teams in the United States, Canada and ‒ for the first time ‒ Brazil. Tom commented on the recognition, saying, “It is a great honor to receive this award. The recognition of this award, however, is not through my efforts alone; it has come about through the support of my family and the teamwork and collaboration that is at the heart of practicing at Duane Morris. I am most grateful to LMG Life Sciences and all who supported naming me as the recipient of this award, and to all of my family and Duane Morris colleagues, without whose support, synergy, and hard work the results underlying this award would not have been possible.”

Thomas J. Kowalski is a seasoned, registered U.S. patent attorney and a partner in the firm’s New York office. He is chair of the Life Sciences, Pharmaceuticals and Biotechnology Division of the firm's Intellectual Property Practice Group and is a member of the firm’s Life Sciences and Medical Technologies Industry Group. His practice includes biotechnology, chemical and medical apparatus patent litigation/contentious matters, prosecution, licensing, investor due diligence, and counseling. He has extensive experience in matters of personal and personalized medicine, genetics and genetic engineering, plant varieties and genetically modified plants, biological inventions arising from big data/data mining/AI (including from data from massively parallel sequencing, transcriptome analyses, single cell genomics, cell signatures and various tools such as DropSeq, RNASeq and PerturbSeq), virology, immunology, antibodies, vaccinology, T-cell receptors, cell-based therapies such as tumor infiltrating lymphocytes, biologics, pharmaceuticals, medicinal chemistry, crystallography and small molecules, amongst other fields of biotechnology and chemistry. Tom also represents clients in procuring trademark and design patent rights, domestically and worldwide, and in enforcing and defending such rights, and in defending clients accused of infringement of such rights, in the United States. Tom has extensive domestic U.S. and international experience, and has represented clients in various proceedings before the USPTO and in a variety of U.S. Courts, as well as throughout the world, including in London, England; The Hague, The Netherlands; Dusseldorf, Mannheim and Munich, Germany; Vienna, Austria; Tokyo, Japan; Melbourne and Canberra, Australia; and Rio de Janeiro, Brazil. Moreover, Tom actively works with clients on strategies to avoid litigation, navigate IP minefields, and maximize patent portfolios and investor funding.

About Duane Morris

Duane Morris LLP provides innovative solutions to today’s multifaceted legal and business challenges through the collegial and collaborative culture of its more than 900 attorneys in offices across the United States and internationally. The firm represents a broad array of clients, spanning all major practices and industries. Duane Morris has been recognized by BTI Consulting as both a client service leader and a highly recommended law firm.